Form 4 for MDT Medtronic
Accepted 2021-09-01 00:00:00 ET · period of report 2021-08-31 · accession 0001127602-21-024699 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-01 | 2021-08-31 | MDT | Lerman Bradley E | SVP GC, Corp Sec | M - OptEx | $74.84 | +50.8K | 99.5K | +104% | +$3.80M |
| D | 2021-09-01 | 2021-08-31 | MDT | Lerman Bradley E | SVP GC, Corp Sec | S - Sale+OE | $134.17 | -50.8K | 48.8K | -51% | -$6.81M |
| D | 2021-09-01 | 2021-08-31 | MDT | Lerman Bradley E | SVP GC, Corp Sec | M - OptEx | $0.00 | -50.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-31 | M | A | 50,775 | $74.84 | 99,538 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-31 | S | D | 50,775 | $134.17 | 48,763 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-31 | M | D | 50,775 | $0.00 | 0 | D | $74.84 · — to 2025-01-27 | 50,775 Ordinary Shares | (F2) This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018. (F3) This date was previously reported incorrectly as 7/28/2024. |